Nasdaq
$2.41▲ 0.21%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $9.6MShares out 4.0M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
21- 10.8Regular26.10.09 01:52DOther#●●●#●●●
SeaStar Medical Holding Corp
SeaStar Medical Holding Corp filed a Form D with the SEC on October 8, 2026, regarding an exempt offering of securities. This filing relates to the issuance of new shares for the company's capital raising activities.…more
$2.41+0.21%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.5After-hours26.10.06 05:208-KKey event
SeaStar Medical Holding Corp
SeaStar Medical has entered into agreements with existing warrant holders to exercise 854,002 warrants for cash at a reduced price of $3.866 per share, generating approximately $3.3 million in gross proceeds. In consideration, the company issued new unregistered Series A and Series B warrants to purchase an aggregate of 1,708,004 shares of common stock. The proceeds are intended for general corporate purposes, including working capital and capital expenditures.…more
$2.41+0.21%vs prev closeView filingShare - 8.19After-hours26.08.20 05:214Ownership
SeaStar Medical Holding Corp
SeaStar Medical Holding Corp insider Michael Messinger reported a change in beneficial ownership of securities via a Form 4 filing dated August 18, 2026. This filing serves as a standard disclosure of equity transactions by company management.…more
$2.41+0.21%vs prev closeView filingShare
20 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoRegular26.10.23 01:01#●●●#●●●
SeaStar Medical Reports Positive Survival Data for Pediatric AKI Treatment…more
SeaStar Medical announced that its QUELIMMUNE therapy demonstrated statistically significant improvements in survival rates for pediatric patients with sepsis-associated acute kidney injury. While the real-world registry data is promising, investors should monitor how these findings translate into broader commercial adoption and financial performance.…more
$2.41+0.21%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 10.14Pre-market26.10.14 21:37
●●●●●●●● ●●●●● ●●●●●●
SeaStar Medical's Chief Medical Officer, Dr. Kevin Chung, has been honored with the 2026 Combat Nephrology Award for his contributions to critical care nephrology. While this recognition highlights the company's clinical expertise, it does not have a direct impact on immediate financial performance.…more
$2.41+0.21%vs prev close - 10.7Pre-market26.10.07 21:17
●●●●●●●● ●●●●● ●●●●●●
SeaStar Medical has received FDA Breakthrough Device Designation for its Selective Cytopheretic Device therapy to treat hyperinflammation in sepsis patients. This designation aims to accelerate the development and review process, though further clinical validation remains necessary for commercial success.…more
$2.41+0.21%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report